Related Experiment Video
Updated: May 31, 2026

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
Published on: September 5, 2017
[Drug-resistant Mycobacterium tuberculosis in children under 15 years]
Claudia Llerena1, Santiago Elías Fadul, María Consuelo Garzón
1Grupo de Micobacterias, Instituto Nacional de Sa, Bogotá, DC, Colombia. cllerena@ins.gov.co
Introduction:
Tuberculosis is a widespread and increasingly important infectious disease. A third of the world-wide population is infected. Every year nine million cases occur in the world, one million of them appearing in children under 15 years old. In Colombia alone, 719 cases were reported for the year 2008.
Objective:
The incidence of Mycobacterium tuberculosis resistant forms was characterized in children under 15 years old in Colombia.
Materials And Methods:
Mycobacterium tuberculosis drug susceptibility test data from 2001 to mid year 2009 were analyzed at the Laboratorio Nacional de Referencia, Instituto Nacional de Salud, Bogotá, Colombia. Cases were evaluated by patient age, disease geographic location, and type of sample, as well as the proportions of TB/HIV coinfections and drug resistance.
Results:
Of the 128 patients examined, 66 were female (52%) and 62 were male (48%). The age group 0 to 5 years old consisted of 59 cases (46%), 21 cases were 6 to 10 years old (16%) and 48 cases 11 to 14 years old (37.5%). The types of disease were 89 (69.6%) pulmonary, 34 (26.4%) extrapulmonary, and 5 (3.9%) cases without data. TB/VIH coinfection cases were 7(5.4%). 123 (96%) untreated cases and 5 (2.34%) cases previously treated. Global resistance among the untreated cases was 21.1% and MDR-TB was 6.5%.
Conclusion:
This analysis demonstrated weaknesses in following established procedures in the TB treatment process, thereby impeding the diagnosis and the identification of drug resistance s in children under 15 years old. Approaches to improving treatment standards is a topic which requires further exploration.
Related Concept Videos
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Tuberculosis
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
